30142 WIXOM ROAD, WIXOM, MI
Announces Second Quarter 2026 Results
Investor Presentation
Regains Compliance with Nasdaq Listing Requirements
Rockwell Medical Implements 1-for-10 Reverse Stock Split Effective July 1, 2026
2026 Annual Meeting Results - Directors Elected and Compensation Approved
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload